Allogene Therapeutics
ALLO
ALLO
162 hedge funds and large institutions have $3.21B invested in Allogene Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $3.8B → $3.21B (-$587M)
24% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 38
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
162
Holding in Top 10
4
Calls
$5.54M
Puts
$5.32M
Top Buyers
| 1 | +$23M | |
| 2 | +$22.1M | |
| 3 | +$19.6M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12.4M |
Top Sellers
| 1 | -$60.9M | |
| 2 | -$54.8M | |
| 3 | -$48.3M | |
| 4 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$37.7M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$30.8M |